Showing results (2351-2360 of 3,162) with videos related to

Sort By:
Pageof 317
Neuro-Oncology|November 24, 2022
Impact of maximal extent of resection on postoperative deficits, patient functioning, and survival within clinically important glioblastoma subgroupsJasper K W Gerritsen, Rosa H Zwarthoed, John L Kilgallon, et al.
Neuro-Oncology|October 17, 2020
Population-based estimates of survival among elderly patients with brain metastasesNayan Lamba, Rachel Brigell Kearney, Paul J Catalano, et al.
Neuro-Oncology|October 17, 2020
Associations of meningioma molecular subgroup and tumor recurrenceMark W Youngblood, Danielle F Miyagishima, Lan Jin, et al.
Neuro-Oncology|October 17, 2020
The natural history of vestibular schwannoma growth-prospective 40-year data from an unselected national cohortMartin Reznitsky, Mette Marie Babiel Schmidt Petersen, Niels West, et al.
Neuro-Oncology|February 1, 2020
Final report from Intergroup NCCTG 86-72-51 (Alliance): a phase III randomized clinical trial of high-dose versus low-dose radiation for adult low-grade gliomaWilliam G Breen, S Keith Anderson, Xiomara W Carrero, et al.
Neuro-Oncology|January 24, 2020
Germline cancer predisposition variants and pediatric glioma: a population-based study in CaliforniaIvo S Muskens, Adam J de Smith, Chenan Zhang, et al.
Neuro-Oncology|February 29, 2020
Resting-state fMRI detects alterations in whole brain connectivity related to tumor biology in glioma patientsVeit M Stoecklein, Sophia Stoecklein, Franziska Galiè, et al.
Neuro-Oncology|July 14, 2021
Inhibition of nicotinamide phosphoribosyltransferase (NAMPT), the rate-limiting enzyme of the nicotinamide adenine dinucleotide (NAD) salvage pathway, to target glioma heterogeneity through mitochondrial oxidative stressPratibha Sharma, Jihong Xu, Katie Williams, et al.
Neuro-Oncology|June 9, 2021
The use of external control data for predictions and futility interim analyses in clinical trialsSteffen Ventz, Leah Comment, Bill Louv, et al.
Neuro-Oncology|December 28, 2020
Transcription factor networks of oligodendrogliomas treated with adjuvant radiotherapy or observation inform prognosisJonathan So, Yasin Mamatjan, Gelareh Zadeh, et al.
Pageof 317